Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Obinna Chijioke

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood|July 31, 2010
Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competenceTill Strowig, Obinna Chijioke, Paolo Carrega, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Infection and immune control of human oncogenic γ-herpesviruses in humanized miceDonal McHugh, Nicole Caduff, Anita Murer, et al.
European Journal of Immunology|August 6, 2013
Infectious diseases in humanized miceCarol Leung, Obinna Chijioke, Cornelia Gujer, et al.
Plos Pathogens|May 1, 2018
EBV persistence without its EBNA3A and 3C oncogenes in vivoAnita Murer, Donal McHugh, Nicole Caduff, et al.
BMC Medicine|October 23, 2016
Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cellsMargarida Ferreira-Teixeira, Daniela Paiva-Oliveira, Belmiro Parada, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
Blood|September 11, 2014
Role for early-differentiated natural killer cells in infectious mononucleosisTarik Azzi, Anna Lünemann, Anita Murer, et al.
Molecular Therapy. Oncology|February 2, 2026
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cellsJuliane Mietz, Lukas Egli, Meike Misiune, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2020
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patientsIlaria Alborelli, Ivana Bratic Hench, Obinna Chijioke, et al.
Molecular Therapy. Methods & Clinical Development|April 3, 2023
Targeted adenovirus-mediated transduction of human T cells <i>in vitro</i> and <i>in vivo</i>Patrick C Freitag, Meike Kaulfuss, Lea Flühler, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|July 31, 2010
Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competenceTill Strowig, Obinna Chijioke, Paolo Carrega, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Infection and immune control of human oncogenic γ-herpesviruses in humanized miceDonal McHugh, Nicole Caduff, Anita Murer, et al.
European Journal of Immunology|August 6, 2013
Infectious diseases in humanized miceCarol Leung, Obinna Chijioke, Cornelia Gujer, et al.
Plos Pathogens|May 1, 2018
EBV persistence without its EBNA3A and 3C oncogenes in vivoAnita Murer, Donal McHugh, Nicole Caduff, et al.
BMC Medicine|October 23, 2016
Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cellsMargarida Ferreira-Teixeira, Daniela Paiva-Oliveira, Belmiro Parada, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
Blood|September 11, 2014
Role for early-differentiated natural killer cells in infectious mononucleosisTarik Azzi, Anna Lünemann, Anita Murer, et al.
Molecular Therapy. Oncology|February 2, 2026
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cellsJuliane Mietz, Lukas Egli, Meike Misiune, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2020
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patientsIlaria Alborelli, Ivana Bratic Hench, Obinna Chijioke, et al.
Molecular Therapy. Methods & Clinical Development|April 3, 2023
Targeted adenovirus-mediated transduction of human T cells <i>in vitro</i> and <i>in vivo</i>Patrick C Freitag, Meike Kaulfuss, Lea Flühler, et al.
Pageof 5